It has been prompted by fresh data from a new cohort of patients in its phase 1b trial of RGLS8429 in ADPKD, a leading cause of end-stage renal disease, which affects around 160,000 people in the ...

A study of real-world patients with ADPKD supports tolvaptan’s role in slowing annual eGFR decline. Treatment with tolvaptan modestly but significantly attenuates long-term decline of kidney ...

A multicenter study from the Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease has furthered understanding of the relationship between rates of kidney enlargement and decline ...

ADPKD, or autosomal dominant polycystic kidney disease, can cause severe pain, headaches, and more problems. What can you do to feel better and stay active? Find exercise and diet tips, pain ...

For more information on ADPKD you can visit ADPKDQuestions.com. This segment aired on the KTLA 5 Morning News on Oct. 27, 2023. Olympic Gold Medalist Missy Franklin shares her personal … ...